Genentech Pays Royalties to OHSU for OCT Patents
Oregon Health & Science UniversityHigher Ed · Portland, OR- Disclosed value
- Patent royalty (amount not specified)
- From agenda
- Document date
- Jan 25, 2024
The 30-second brief
OHSU and Dr. David Huang receive ongoing patent royalties from Genentech for contributions to OCT technological innovation.
GENENTECH holds this contract with Oregon Health & Science University. Its other public contracts on record include work for Dixon Unified and South San Francisco Unified.
See every contract and contact at Oregon Health & Science University.
See every contractFree account · 30-second setup · No credit card
Contract details
- Amount
- Patent royalty (amount not specified)
- Document date
- January 25, 2024
- Vendor
- GENENTECH
- Source document
- oregon-health-science-university-board-of-directors-public-agenda-jan-25-2024_d0f.pdf (Agenda)
GENENTECH's other public contracts
More Oregon Health & Science University contracts
Questions about this contract
Who was awarded the government contract by Oregon Health & Science University?
GENENTECH was awarded this government contract by Oregon Health & Science University, as recorded on January 25, 2024.
What type of contract is this?
This is a government contract, documented as a agenda record.
Where was this contract approved?
This contract appears in oregon-health-science-university-board-of-directors-public-agenda-jan-25-2024_d0f.pdf (Agenda), dated January 25, 2024 from Oregon Health & Science University. Civic IQ extracts contract records directly from agency meeting documents and solicitations.
What other contracts does GENENTECH hold?
GENENTECH may hold additional government contracts. View their full contract history, the agencies they serve, and total tracked spend on their Civic IQ vendor profile.
Show 1 more question
What is Oregon Health & Science University currently buying?
Explore Oregon Health & Science University's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.